REFERENCES
Abraham, G.E., Odell, W.D., Swerdloff, R.S and Hopper, K. (2012).Simultaneous radioimmunoassay of plasma FSH, LH, progesterone,17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle.Journal of Clinical Endocrinology.34:312-318.
American Diabetes Association (2008).Economic consequences of diabetes mellitus in the United State. Diabetes Care. 21:296-309.
Anderson, L.A., McTernan, P.G., Barnett, A.H. and Kumar, S. (2001). The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. Journal of Clinical Endocrinology and metabolism .86:5045–5051.
Anderson, R.M., Donnelly, M.B. and Davis, W.K. (2012).Controversial beliefs about diabetes and its care. Diabetes Care. 15:859-863.
Bailey, C.J. and Turner, R.C. (2016). Metformin. New England Journal of Medicine. 334:574–579.
Baker, M.E. (2013). What are the physiological estrogens?.Steroids.78 (3): 337–340.
Bennett, W.L., Maruthur, N.M. and Singh, S. (2011). Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Annals of International Medicine. 154:602–613.
Bhavnani, B.R., Nisker, J.A., Martin, J., Aletebi, F., Watson, L. and Milne, J.K. (2010).Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women. Journal of Social Gynecology Investigation .7(3):175–183.
Blouin, K., Nadeau, M. andMailloux, J, (2011). Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. American Journal of Physiology, Endocrinology and Metabolism. 296: 244-255.
Bouchoucha, M., Uzzan, B. and Cohen, R. (2011). Metformin and digestive disorders. Diabetes Metabolism.37:90–96.
Brisken, C. and O'Malley, B. (2010). Hormone action in the mammary gland. Cold Spring Harbour and Perspective Biology.2(12): 231-236.
Brown, K.A., Samarajeewa, N.U. and Simpson, E.R. (2013).Endocrine-related cancers and the role of AMPK. Molecular and Cellular Endocrinology. 366:170-179.
Brown, L.M., Gent, L., Davis, K. and Clegg, D.J. (2010).Metabolic impact of sex hormones on obesity. Brain Research. 1350:77–85.
Burger, H.G. (2012). Androgen production in women. Fertility and Sterility. 77(4): 3–5.
Burtis, C.A., Ashwood, E.R. and Bruns, D.E. (2008).Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. India: Reed Elsevier. pp. 854-900.
Campagnoli, C., Pasanisi, P., Abbà , C., Ambroggio, S., Biglia, N., Brucato, T., Colombero, R., Danese, S., Donadio, M., Venturelli, E., Zito, Z. And Berrino, F. (2012). Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: A randomized study. Clinical Breast Cancer.12(3): 175-82.
Chan, N.N., Brain, H.P. and Feher, M.D. (2009).Metformin-associated lacticacidosis: a rare or very rare clinical entity?.Diabetes Medication. 16:273–281.
Charlton H (2008). "Hypothalamic control of anterior pituitary function: a history".J. Neuroendocrinol. 20 (6): 641–646.
Christensen, A., Dewing, P. And Micevych, P. (2011).Membrane-initiated estradiol signalling induces spinogenesis required for female sexual receptivity. Journal of Neuroscience. 31(48): 17583–17589.
Danforth, K.N., Eliassen, A.H. and Tworoger, S.S.(2010). The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. International Journal of Cancer. 126:199-207.
Davidson, M.B. and Peters, A.L. (2017).An overview of metformin in the treatment of type 2 diabetes mellitus. American Journal of Medicine. 102:99–110.
DeFronzo, R., Fleming, G.A., Chen, K. and Bicsak, T.A. (2016). Metformin associated lactic acidosis: current perspectives on causes and risk. Metabolism. 65:20–29.
DeFronzo, R.A. and Goodman, A.M. (2005). The Multicenter Metformin Study Group -Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. New England Journal of Medicine. 333:541–549.
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A. and Dandona, D. (2009). Frequent occurrence of hypogonadism in type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism. 90:1903
Ding, E.L., Song, Y. and Manson, J.E. (2009). Sex hormone-binding globulin and risk of type 2 diabetes in women and men. New England Journal of Medicine. 361: 1152–1163.
Eriksson, E. and Nystrom, T. (2015). Antidiabetic agents and endothelial dysfunction – beyond glucose control. Basic and Clinical Pharmacology and Toxicology. 117: 15–25
Fauci, A.S., Braunwald, E., Kasper, D.L., Hauser, S.L., Longo, D.L., Jameson, J.L. and Loscalzo, J. (2008). Harrison’s principles of internal medicine. 17th edition. McGraw-Hill. Pp 2275-2302.
Files, J.A., K. O, M.G. and Pruthi, S. (2011). Bioidentical hormone therapy. Mayo Clinical Procedure. 86(7):673–680.
Freeman, J. and Loewe, R. (2010).Barriers to communication about diabetes mellitus Patients’ and physicians’ different view of the disease. Journal of Family Practice. 49(6):507-512.